422 related articles for article (PubMed ID: 36623520)
21. Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study.
Meng M; Wei R; Wu Y; Zeng R; Luo D; Ma Y; Zhang L; Huang W; Zeng H; Leung FW; Qiu X; Sha W; Chen H
EClinicalMedicine; 2024 Mar; 69():102500. PubMed ID: 38389713
[TBL] [Abstract][Full Text] [Related]
22. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo).
Deuel JW; Lauria E; Lovey T; Zweifel S; Meier MI; Züst R; Gültekin N; Stettbacher A; Schlagenhauf P
Lancet Infect Dis; 2022 Dec; 22(12):1694-1702. PubMed ID: 36030795
[TBL] [Abstract][Full Text] [Related]
23. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
[TBL] [Abstract][Full Text] [Related]
24. High-dimensional characterization of post-acute sequelae of COVID-19.
Al-Aly Z; Xie Y; Bowe B
Nature; 2021 Jun; 594(7862):259-264. PubMed ID: 33887749
[TBL] [Abstract][Full Text] [Related]
25. Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study.
Richard L; Booth R; Rayner J; Clemens KK; Forchuk C; Shariff SZ
CMAJ Open; 2021; 9(1):E1-E9. PubMed ID: 33436450
[TBL] [Abstract][Full Text] [Related]
26. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
[TBL] [Abstract][Full Text] [Related]
27. Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study.
McNaughton CD; Austin PC; Sivaswamy A; Fang J; Abdel-Qadir H; Daneman N; Udell JA; Wodchis WP; Mostarac I; Lee DS; Atzema CL
CMAJ; 2022 Oct; 194(40):E1368-E1376. PubMed ID: 36252983
[TBL] [Abstract][Full Text] [Related]
28. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
[TBL] [Abstract][Full Text] [Related]
29. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
30. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
32. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.
Daugherty SE; Guo Y; Heath K; Dasmariñas MC; Jubilo KG; Samranvedhya J; Lipsitch M; Cohen K
BMJ; 2021 May; 373():n1098. PubMed ID: 34011492
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
34. Epidemiologic Features of Recovery From SARS-CoV-2 Infection.
Oelsner EC; Sun Y; Balte PP; Allen NB; Andrews H; Carson A; Cole SA; Coresh J; Couper D; Cushman M; Daviglus M; Demmer RT; Elkind MSV; Gallo LC; Gutierrez JD; Howard VJ; Isasi CR; Judd SE; Kanaya AM; Kandula NR; Kaplan RC; Kinney GL; Kucharska-Newton AM; Lackland DT; Lee JS; Make BJ; Min YI; Murabito JM; Norwood AF; Ortega VE; Pettee Gabriel K; Psaty BM; Regan EA; Sotres-Alvarez D; Schwartz D; Shikany JM; Thyagarajan B; Tracy RP; Umans JG; Vasan RS; Wenzel SE; Woodruff PG; Xanthakis V; Zhang Y; Post WS
JAMA Netw Open; 2024 Jun; 7(6):e2417440. PubMed ID: 38884994
[TBL] [Abstract][Full Text] [Related]
35. HDL cholesterol levels and susceptibility to COVID-19.
Chidambaram V; Kumar A; Majella MG; Seth B; Sivakumar RK; Voruganti D; Bavineni M; Baghal A; Gates K; Kumari A; Al'Aref SJ; Galiatsatos P; Karakousis PC; Mehta JL
EBioMedicine; 2022 Aug; 82():104166. PubMed ID: 35843172
[TBL] [Abstract][Full Text] [Related]
36. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.
Mizrahi B; Sudry T; Flaks-Manov N; Yehezkelli Y; Kalkstein N; Akiva P; Ekka-Zohar A; Ben David SS; Lerner U; Bivas-Benita M; Greenfeld S
BMJ; 2023 Jan; 380():e072529. PubMed ID: 36631153
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
38. Three-year outcomes of post-acute sequelae of COVID-19.
Cai M; Xie Y; Topol EJ; Al-Aly Z
Nat Med; 2024 Jun; 30(6):1564-1573. PubMed ID: 38816608
[TBL] [Abstract][Full Text] [Related]
39. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
[TBL] [Abstract][Full Text] [Related]
40. Risk of Suicide-Related Outcomes After SARS-COV-2 Infection: Results from a Nationwide Observational Matched Cohort of US Veterans.
Hynes DM; Niederhausen M; Chen JI; Shahoumian TA; Rowneki M; Hickok A; Shepherd-Banigan M; Hawkins EJ; Naylor J; Teo A; Govier DJ; Berry K; McCready H; Osborne TF; Wong E; Hebert PL; Smith VA; Bowling CB; Boyko EJ; Ioannou GN; Iwashyna TJ; Maciejewski ML; O'Hare AM; Viglianti EM; Bohnert AS
J Gen Intern Med; 2024 Mar; 39(4):626-635. PubMed ID: 37884839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
